Literature DB >> 20621049

Patients beware: commercialized stem cell treatments on the web.

Patrick L Taylor1, Roger A Barker, Karl G Blume, Elena Cattaneo, Alan Colman, Hongkui Deng, Harold Edgar, Ira J Fox, Claude Gerstle, Lawrence S B Goldstein, Katherine A High, Andrew Lyall, Robertson Parkman, Fernando J Pitossi, Ernest D Prentice, Heather M Rooke, Douglas A Sipp, Alok Srivastava, Susan Stayn, Gary K Steinberg, Amy J Wagers, Irving L Weissman.   

Abstract

A report by the International Society for Stem Cell Research (ISSCR)'s Task Force on Unproven Stem Cell Treatments outlines development of resources for patients, their families, and physicians seeking information on stem cell treatments. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20621049     DOI： 10.1016/j.stem.2010.06.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  18 in total

1.  Cell-assisted lipotransfer.

Authors:  Soraya Grabin; Gerd Antes; G Björn Stark; Edith Motschall; Sabine Buroh; Florian M Lampert
Journal:  Dtsch Arztebl Int       Date:  2015-04-10       Impact factor: 5.594

2.  Perspectives on strategies and challenges in the conversation about stem cells for spinal cord injury.

Authors:  K J Jacob; B K Kwon; C Lo; J Snyder; J Illes
Journal:  Spinal Cord       Date:  2015-06-02       Impact factor: 2.772

3.  Policy: Global standards for stem-cell research.

Authors:  Jonathan Kimmelman; Insoo Hyun; Nissim Benvenisty; Timothy Caulfield; Helen E Heslop; Charles E Murry; Douglas Sipp; Lorenz Studer; Jeremy Sugarman; George Q Daley
Journal:  Nature       Date:  2016-05-19       Impact factor: 49.962

Review 4.  The unregulated commercialization of stem cell treatments: a global perspective.

Authors:  Douglas Sipp
Journal:  Front Med       Date:  2011-10-01       Impact factor: 4.592

5.  Toward a knowledge of causes.

Authors:  Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

6.  Stem cell trials for cardiovascular medicine: ethical rationale.

Authors:  Sophie L Niemansburg; Martin Teraa; Husna Hesam; Johannes J M van Delden; Marianne C Verhaar; Annelien L Bredenoord
Journal:  Tissue Eng Part A       Date:  2013-12-11       Impact factor: 3.845

7.  The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies.

Authors:  Alan Trounson; Natalie D DeWitt; Ellen G Feigal
Journal:  Stem Cells Transl Med       Date:  2012-01       Impact factor: 6.940

8.  A single epidermal stem cell strategy for safe ex vivo gene therapy.

Authors:  Stéphanie Droz-Georget Lathion; Ariane Rochat; Graham Knott; Alessandra Recchia; Danielle Martinet; Sara Benmohammed; Nicolas Grasset; Andrea Zaffalon; Nathalie Besuchet Schmutz; Emmanuelle Savioz-Dayer; Jacques Samuel Beckmann; Jacques Rougemont; Fulvio Mavilio; Yann Barrandon
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

9.  Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.

Authors:  Alison K McLean; Cameron Stewart; Ian Kerridge
Journal:  Stem Cell Res Ther       Date:  2015-02-09       Impact factor: 6.832

10.  ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.

Authors:  Leigh Turner
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.